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Abstract 
Aims and objectives 
To explore the experiences of smoking and quitting attempts in people with Type 1 Diabetes 
(T1D), including their perceptions of existing services for smoking cessation. 
Background 
In the UK, approximately a fifth of the population with T1D smoke and despite the adverse 
effects of smoking, these individuals continue with their smoking habits. There is limited 
information on the barriers and facilitators to quitting smoking in people with T1D.  
Methods: This study adopted a qualitative study design using semi-structured individual 
interviews guided by PRIME theory. Participants (n = 12) were purposively sampled and 
recruited from two diabetes outpatient clinics in London (UK). Audio-recorded interviews 
were transcribed verbatim and analysed using the Framework method.  
Results 
Most smokers with T1D reported lack of motivation to stop smoking due to the addictive nature 
of cigarettes. Further barriers to quitting included self-image and habits associated with 
smoking; such as social activities. Generally, most reported limited awareness about the risks 
associated to smoking and diabetes. Moreover, the perceived negative attitude towards nicotine 
replacement therapy and pharmacotherapy impeded their willingness to alter their smoking 
habits. Nonetheless, these patients suggested that informative guidance from medical 
professionals and strategies to tackle cravings related to nicotine as helpful approaches to 
improve quitting attempts.  
Conclusion 
Internal and external factors influence quitting attempts among smokers with T1D, with 
particular emphasis on self-image and societal norms. It is evident that existing strategies for 
smoking cessation recommended by the National Institute for Health and Care Excellence have 
either not been implemented or not well-received by people with T1D.  
Relevance to clinical practice 
Strategies and resources, such as staff training, to increase delivery of smoking cessation 
support to patients with diabetes are needed. 
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What does this paper contribute to the wider global clinical community? 
• Despite existing resources and services for smoking cessation, people with Type 1 Diabetes 
(T1D) are not motivated to quit smoking and deem these measures as ineffective.  
• Self-image, societal pressures and misconceptions about nicotine replacement therapy are 
key factors that hinder quitting attempts among individuals with T1D.  
• Limited educational and healthcare support are offered to people with diabetes who smoke.   
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Introduction 
In the UK, 15.5% of the adult population smoke (Office for National Statistics, 2017) and the 
smoking prevalence is similar for Type 1 Diabetes (T1D) (17%) but slightly lower in Type 2 
Diabetes (T2D) (12%) (NHS Digital, 2017). In 2006, it was estimated that £5.2 billion was 
spent by the National Health Services (NHS) for smoking-related ill health; accounting for 
5.5% of the total health care expenditure (Health and Social Care Information Centre, 2015). 
Smoking has been shown to enhance the risk of morbidity and mortality among people with 
diabetes (Lopez Zubizarreta, Hernandez Mezquita, Miralles Garcia, & Barrueco Ferrero, 
2017). In 2010/11, the financial costs of complications of diabetes to the NHS amounted to £8 
billion, and this cost is projected to increase to £13.5 billion in 2035/2036 (Hex, Bartlett, 
Wright, Taylor, & Varley, 2012).  
  
According to the 2015-2016 UK national diabetes audit report, fewer patients with T1D 
(78.5%) received care for smoking in comparison to Type 2 Diabetes (T2D) (85.2%) (NHS 
Digital, 2017). However, it is not clear what form of care; such as brief advice, behavioural 
support, nicotine replacement therapy [NRT]), was offered to these patient groups. 
Nonetheless, people with diabetes who quit smoking were reported to improve their glycaemic 
control (Lycett et al., 2015), reduce their odds of all-cause mortality (Blomster et al., 2016) and 
had 40% fewer hospital admissions (Tran, Falster, Douglas, Blyth, & Jorm, 2015). Moreover, 
individuals with T1D would probably gain more immediate benefit from quitting than people 
with T2D (Lycett et al., 2015). Therefore, quitting smoking would overall improve health 
outcomes and could decrease health care expenditure associated with diabetes and its 
secondary complications. 
 
 
Background 
The National Institute for Health and Care Excellence (NICE) guidelines propose NRT, 
pharmacotherapy and counselling for patients who wish to quit smoking (National Institute for 
Health and Care Excellence, 2013). Whilst every smoker is different, there are some groups 
that have enough in common to justify the development of tailored evidence-based approaches 
to smoking cessation. People with diabetes have difficulties coping with the expected changes 
in their lifestyle and patients with T2D have been found to hold misconceptions which affect 
their intention to quit smoking (Chau et al., 2015). There is a dearth of evidence of efficacy on 
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tailored smoking interventions for diabetic patients (Nagrebetsky, Brettell, Roberts, & Farmer, 
2014). However, a retrospective pooled analysis of 15 RCTs examining the efficacy of the 
smoking cessation drug varenicline in smokers with diabetes showed a higher abstinence rate 
in the intervention arm compared to the placebo group at 3 months (43.8% and 24.8%, 
respectively) (Tonstad & Lawrence, 2017). The abstinence rate markedly declined to 18.4% 
after 1 year follow-up in the varenicline-treated group (Tonstad & Lawrence, 2017); suggesting 
short-term benefit. Psychotherapeutic approaches to quit smoking in people with diabetes 
showed a success rate between 17% - 50% (Canga et al., 2000; Hokanson, Anderson, 
Hennrikus, Lando, & Kendall, 2006; Persson & Hjalmarson, 2006; Thankappan et al., 2013). 
Moreover, patients in the nurse-led smoking cessation intervention group, who continued to 
smoke, significantly reduced their cigarette consumption by 23% at 6 months follow-up (Canga 
et al., 2000). Only one RCT examined relapse at 6 months follow-up after a smoking cessation 
intervention (Hokanson et al., 2006), and only one trial included a 12-month follow-up but did 
not assess relapse (Persson & Hjalmarson, 2006). Thus, it is not clear whether relapse would 
be greater in a trial with a follow-up period longer than 6 months.  
 
Whilst most of the literature focuses on smoking and smoking cessation in T2D, little is known 
about the experiences of people with T1D. Moreover, it is not clear which resources or services 
for smoking cessation would be most useful for T1D, as authors mostly assessed patients with 
T2D or pooled analysis of both types of diabetes (Canga et al., 2000; Hokanson et al., 2006). 
The smoking behaviour of patients with T2D, as well as current and former smokers without 
diabetes, was previously examined using various theoretical frameworks including theory of 
planned behaviour and PRIME respectively (Chau et al., 2015; Uppal, Shahab, Britton, & 
Ratschen, 2013; Vangeli & West, 2012). PRIME (plans, responses, impulses, motives and 
evaluations) theory of motivation explores the underlying components involved in the 
decision-making process to quit smoking, assessing people’s beliefs, responses, impulses, 
motives and plans to alter their smoking behaviour (West, 2009). Cigarette addiction arises 
from multiple sources feeding into the motivational system; including the feelings of ‘wanting’ 
to smoke to achieve pleasure and satisfaction, the ‘need’ to smoke to quell the ‘nicotine hunger’ 
and beliefs on the benefits of smoking. These constructs along with external cues influence the 
end point response deterring quitting attempts and prompting smoking relapse events (McEwan 
& West, 2010).   Knowledge of the different components involved in tobacco addiction could 
inform policymakers to develop more robust smoking cessation interventions for populations 
who present chronic conditions.  
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Aims of the study 
To explore the beliefs, experiences and attitudes of smokers with T1D towards smoking and 
its cessation using a qualitative approach using PRIME theory. 
 
Methods 
Design 
This qualitative study used semi-structured, audio-recorded individual interviews to understand 
the experiences and beliefs of smokers with T1D towards smoking and quitting smoking, 
including their perceptions of existing services for smoking cessation.  
 
Participants and settings 
Twelve out of 14 eligible participants were recruited from two diabetes outpatient clinics in 
London (UK) using purposive sampling based on the eligibility criteria including patients 
above 18 years of age with T1D, current or occasional smokers who have smoked at least 100 
cigarettes in their lifetime and able to converse in English. Individuals with T2D, ex-smokers 
and non-smokers with T1D were excluded from the study. Study details were conveyed by 
diabetes specialist nurses and further information was provided by the primary investigator. 
Written informed consent was obtained face-to-face or by post prior to the start of the study. 
Recruitment continued until data saturation was achieved, whereby no new information was 
obtained.  No monetary or other incentives were given for participation.  
 
Data collection 
Before the interview, participants completed a questionnaire on their demographics, diabetes 
and smoking profile either face-to-face (n = 6) or completed by the researcher over Skype (n = 
2) or telephone (n = 4). Individual interviews were conducted by the same researcher in 
privately secured meeting rooms at the diabetes outpatient clinics in London, or via telephone 
or Skype, lasting approximately 35 minutes. An interview topic guide was used to steer the 
individual semi-structured interviews and some of the questions were guided by the PRIME 
theory (West, 2009) addressing: beliefs about smoking, plans to continue or quit smoking. The 
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perceived effectiveness of policies and services for smoking cessation were additionally 
explored (Table 1). Data collection was performed between May 2016 and June 2016. 
 
Data analysis 
Baseline characteristics were expressed as mean ± standard deviation (S.D.) or presented as 
ranges. Recorded audiotapes were transcribed verbatim with anonymisation and subsequently 
coded using NVivo10®. Two authors independently coded the transcripts and analysed the data 
using the Framework approach (Ritchie, Lewis, McNaughton Nicholls, & Ormston, 2013) 
using a combination of inductive and deductive methods, whereby emergent themes were 
identified and then organised according to the different components of the PRIME theory 
respectively (West 2009). The Framework approach was performed in accordance to the 
methods of Ritchie et al. (2013) that comprise of five analytical stages including familiarization 
and coding of textual data, development of thematic framework, indexing of textual data to 
categorised themes, charting the indexed data, and finally mapping and interpreting the charted 
information to finalise the conceptual framework. Discrepancies throughout the analytical 
process were resolved by consensus.  
 
Trustworthiness 
Scientific rigour and transparency of research findings were established by providing thick 
description of the studied phenomenon, investigator triangulation, use of informants’ quotes, 
reflexivity and audit trail. These methods encompass Lincoln and Guba’s approach (Lincoln & 
Guba, 1985) to achieve trustworthiness in qualitative research. Response bias was minimised 
due to the explicit transparency of the researcher’s occupational role; increasing credibility of 
research data. 
 
Reflexivity 
Developing good rapport with participants is imperative to ensure greater response rate and 
avoiding concerns related to judgemental biases. The researcher stated their profession as a 
clinical researcher with a background in psychopharmacology to the participants and 
mentioned that she was not involved in their clinical care. This helped establish a comfortable 
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neutral environment for respondents to disclose their personal information. To validate the 
interpretation of the interview data, two authors independently analysed the qualitative data. 
Results were then compared and reviewed to develop a more broad understanding of the 
studied phenomenon based on each of the investigator’s perspective. Differences in data 
interpretation were resolved through joint discussions until consistency was achieved. 
 
Ethical considerations 
This research was conducted in accordance to the principles of the Declaration of Helsinki 
(seventh revision 2013) (World Medical Association, 2013) and Good Clinical Practice 
(National Institute for Health Research, 2016). Ethical approval for this study was granted by 
South West Exeter Research Ethics Committee (REC reference 16/SW/0048) in the NHS 
Health Research Authority.  
 
Results  
Participant characteristics 
Twelve participants with T1D were recruited and their demographics, smoking and diabetes 
profile are illustrated in Table 2. One third of the participants were female and the mean age of 
the total respondents was 33.7 years (range: 25 – 50). Over 50% of the participants were single 
and two thirds of these individuals have post-secondary education or tertiary educational 
qualifications. Approximately 85% of these patients were employed and all of the sample was 
white. The age of diagnosis for diabetes varied considerably ranging from 3 to 45 years (mean 
17.9 years) and the average years living with diabetes was 15.7 years. All individuals reported 
to manage their diabetes either through multiple daily insulin injections (68%), insulin pump 
(25%) or twice-daily insulin injections (8%).  
 
The smoking profile of the participants indicated that all individuals claimed to have smoked 
at least 100 cigarettes in their lifetime. Only one participant reported to smoke less than one 
cigarette per day whilst the remainder stated to smoke between three to 20 cigarettes daily, 
with a mean of 8.2 (S.D. = 5.4). More than half of the respondents consumed their first cigarette 
in the morning, varying between 10 to 60 minutes after they wake up or as an accompaniment 
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with their morning coffee. Overall, 11 out of 12 participants reported to have attempted to quit 
smoking in the past.  
 
Table 2. Characteristics of smokers with T1D  
Initial analyses through an inductive approach identified 14 codes. These codes were grouped 
into five major themes that coincided with the different components of the PRIME theory. 
Themes and subthemes were then refined and categorised using deductive methods based on 
the constructs of the PRIME theory (Figure 1).  
 
Figure 1. Emergent themes and subthemes in accordance to the PRIME theory. 
 
Plans to alter smoking behaviour  
Most participants believed that their decision-making to abstain from smoking was their 
personal choice and would not influenced by others (Table 3). Some mentioned that they would 
seek smoking cessation guidance and support from their GP and one preferred to search the 
internet for information on smoking cessation support.  
Drinking tea or having food were potential strategies voiced by a few of the respondents to 
help them avoid smoking. Restricting cigarette consumption at home and limiting the number 
of cigarettes taken during outings were anticipated to reduce their nicotine intake (Table 3). 
Implementing a no smoking rule when finances are limited was a strategy that one participant 
set for themselves (Table 3) and setting goals to reduce their cigarette consumption periodically 
could help them during their quitting process.  
 
Table 3. Key subthemes representing the “plans” component of the PRIME theory.  
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Smoking behaviouR in T1D patients  
Participants discussed their smoking history and many mentioned that they started smoking 
due to social conformity and acceptability of tobacco use; whilst others reported that peer 
pressure instigated their smoking behaviour (Table 4). Additionally, various internal and 
external triggers enticed their decision-making to smoke; including curiosity, self-image with 
common depictions of appearing “cool” and seeming “bigger”. These views were also 
similarly shared with the one occasional smoker.  Only one participant stated that they started 
smoking after their diabetes diagnosis (Table 4).  
Most participants reported that their smoking routine was “regimented” and their habits were 
dependent on social activities, personal rituals, work and free time. Being busy deterred their 
attention away from smoking and reduced the number of cigarettes consumed (Table 4).  
Several codes were identified that addressed changes in smoking patterns within the sample 
itself both among the occasional and regular smokers. Increased health awareness, partner’s 
disapproval of smoking, financial restrictions, parenthood, work environment and diagnosis of 
diabetes were listed as factors that altered their smoking behaviour (Table 4). As a result, some 
reduced their cigarette uptake, whilst others changed their smoking location or switched to 
alternative tobacco-based products that were either cheaper or contained less tar and nicotine.  
Interestingly, public smoking bans did not discourage some of the participants from their 
smoking habits and in fact led to the formation of new norms in relation to smoking outside 
(Table 4). 
Nearly all of the participants attempted to quit smoking in their lifetime which was mainly due 
to health reasons associated with their early diagnosis of diabetes or due to some form of 
restrictions; such as hospitalisation, finances or inaccessibility to cigarettes (Table 4). Some 
attempted to quit for personal reasons by hoping to improve their quality of life.  
An array of smoking cessation products and services were tried and tested and were mainly 
NRT-based including patches, lozenges, chewing gum, inhalers and e-cigarettes (Table 4). 
Although, many reflected that they were not informed on how to use them by healthcare 
services. A few participants stopped smoking “cold turkey” and they may or may have not used 
additional methods to aid their quitting attempts. Recommendations on choices of NRT were 
either made through their local GP services or through the Stop Smoking Service at Boots. 
Other non-evidence based measures used to help quit smoking included hypnosis, Allen Carr’s 
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books on quitting smoking and mints. Nonetheless, despite their efforts to quit nearly all of the 
participants relapsed and continued to smoke.   
 
Table 4. Key subthemes representing the “responses” component of the PRIME theory.  
 
Urges that Influence smoking behaviour 
When assessing the views of the study sample towards quitting smoking, a few reported that 
they were not keen to quit. One informant mentioned that reducing their intake of cigarettes 
was considered sufficient and did not account them as a regular smoker. Others inferred that 
they could quit but were not willing to do so during that time as it was not on their mind (Table 
5).  
Some participants claimed that their addictions and cravings maintained their smoking habits 
and others smoked as a reward after a strenuous work day, medicinal usage for pain and/or 
boredom (Table 5). One participant referred to their cigarettes as their “best friend” and a 
source of reliability to cope with their day. Interestingly, less than a half of the studied 
population could not provide reasoning to continue with their smoking habits.  
Participants who used e-cigarettes criticised their effectiveness in quitting smoking as it did not 
hinder the physical act of smoking (Table 5). 
Many participants felt that habits and routines associated with smoking were obstacles to 
quitting. Temptation to smoke predominantly in social settings was voiced as a common barrier 
to refrain from smoking (Table 5). Other impediments included lack of social support and 
dependency on cigarettes to alleviate stress or for emotional support. For others, shame and 
secrecy about smoking deterred their urge to quit. A few participants mentioned that their 
health conditions did not encourage them to quit smoking due to other health priorities. In other 
instances, external forces such as bereavement, depression or troubles with work prompted 
their relapse to cigarettes as a coping mechanism (Table 5).  
 
Table 5. Key subthemes representing the “impulses” component of the PRIME theory.  
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Motives to quit smoking 
Although the majority of participants attempted to quit smoking in the past, many mentioned 
that they lacked will power to sustain their quitting attempts (Table 6).  
Overall, participants acknowledged that they should not be smoking and were aware of the 
negative attributes of cigarettes. However, despite their beliefs they continue to smoke (Table 
6). Moreover, a few of the participants mentioned that they disliked being a smoker but carried 
on smoking nonetheless.  
Participants who attempted to quit in the past employed a variety of strategies to stop them 
from relapsing, including engaging in alternative activities that were not associated with 
smoking; such as cooking or other house chores (Table 6). One participant swapped cigarettes 
with liquorice to help mimic the act of smoking. Some participants practiced meditation to 
strengthen their focus on quitting (Table 6).  
Provision of educational support from health care professionals was expressed as a potential 
influential factor to refrain from smoking by some participants. In addition, external cues such 
as engaging in extra-curricular activities, support from family and friends, and public smoking 
bans could encourage quitting attempts (Table 6). In addition, adopting a healthful lifestyle and 
being mindful of goals helped deflect their attention and desire to smoke (Table 6). Eliminating 
sources of temptation associated with smoking without or with the use of NRT, particularly 
nicotine patches, helped to lessen the cravings associated with cigarettes and discarded the 
physical habit associated with smoking (Table 6). One participant would prefer a more 
“radical” approach to instantly stop smoking through a single intervention; such as an injection 
that triggers a vomiting reflux when they attempt to smoke a cigarette. 
 
Table 6. Key subthemes representing the “motives” component of the PRIME theory. 
 
BEliefs about smoking and smoking cessation strategies 
Smoking was seen as an emotional reliever and some reported that smoking offers them alone 
time to recuperate from their routine activities and responsibilities (Table 7). Smoking was 
positively attributed to feelings of reward and pleasure. The physiological sensation associated 
with the tobacco taste and inhalation process was seen as an alluring reason to smoke (Table 
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7). One informant mentioned that smoking was no longer socially acceptable and perceived as 
“not cool” at the current time; allowing them to reassess their smoking behaviour.  
Most informants were conscious of the adverse effects of smoking on general health (Table 7). 
However, only a few could directly link an association between smoking and diabetes 
complications; whilst others did not believe that there was any correlation between smoking 
and diabetes.  
The poor awareness of the impact of smoking on diabetes was supported by the fact that only 
a few participants were informed of the added risks of smoking on diabetes by healthcare 
professionals, or information given was general and not explicit to their diabetes. Moreover, 
they were never provided information on the association of smoking and diabetes by their 
healthcare providers (Table 7).  
Those who attempted to quit mostly experienced adverse events with NRTs and their use was 
seemingly counter-productive to taper the mental effects and physical habits attributed to 
cigarettes (Table 7). In addition, the ease of use of e-cigarettes and their lessened restrictions 
in comparison to normal cigarettes allowed them to be smoked more frequently (Table 7).  
 
Table 7. Key subthemes representing the “evaluations” component of the PRIME theory. 
 
Discussion 
This study examined the experiences, beliefs and attitudes of smokers with T1D towards 
smoking and its cessation. The existing empirical evidence on smokers with T1D is outdated 
and are derived from studies bearing risk of methodological bias including high risk of 
selection, detection and performance bias. Nonetheless, there is a lack of recent seminal reports 
providing information on perceptions of smokers with diabetes on smoking and diabetes care. 
Therefore, the current findings were compared to previous evidence to identify areas of 
progression within the realm of smoking in the diabetes population, as well as recognising areas 
that yet warrant immediate attention. The present findings illustrated that various intrinsic and 
extrinsic factors influence smoking behaviour in people with T1D; particularly self-image and 
societal norms respectively. Their impulses to continue smoking reflect on the internal 
addictive cravings and external social pressures. Moreover, the negative outcomes associated 
with existing smoking cessation approaches hinder their motivation to quit.  These individuals 
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have proposed numerous strategies to enhance quitting attempts; including active engagement 
from health care services to provide explicit information on the added risks of smoking on their 
diabetes.  
The current study used the PRIME model to identify factors that influence the smoking habits 
of smokers with T1D and their decision-making to quit. The PRIME model emphasises on 
“plans” to develop strategies that would assist them with the intent of quitting smoking. 
Quitting smoking was seen as a personal choice among smokers with T1D and this was also 
perceived by smokers with chronic obstructive pulmonary disease (COPD) with similar 
references to “all in your brain” being echoed by both cohorts when planning to stop smoking 
(Eklund, Nilsson, Hedman, & Lindberg, 2012).  Whilst some would refer to their GP for advice 
and support to quit smoking, a few preferred to seek help on their own. It is plausible that some 
individuals may not want to feel patronised by physicians and therefore avoid seeking their 
support (Eklund et al., 2012). This may be a common concern among smokers with chronic 
conditions as smokers with T1D have also previously criticised healthcare professionals on 
their poor demeanour when providing advice on smoking cessation (Padmawati, Ng, 
Prabandari, & Nichter, 2009).    
Most participants attributed their smoking behaviour, “response” – another element of 
PRIME, to external triggers (social influences) and internal cues (self-image). Some of these 
findings overlap with previous research on adolescent smokers with T1D (Regber & Kelly, 
2007). However, no other studies identified self-image as an instigator to smoking in this 
population.  Only one patient proclaimed that their diabetes diagnosis triggered the onset of 
their smoking behaviour. This notion was never reported in previous research among 
individuals with T1D; illustrating novel findings that will need to be considered in future work. 
In addition, smoking was associated with various activities including alcohol consumption. The 
correlation between tobacco and alcohol intake was previously described among the general 
population of smokers (Uppal et al., 2013); suggesting that engaging in one activity greatly 
increases the tendency of an alternate addictive behaviour (Action on Smoking and Health, 
2015).  
For most, smoking frequency lessened with age due to increased health awareness, diabetes 
status and changes in their social status. Regber and Kelly (2007) reported similar findings in 
adolescent T1D smokers. However, their study population did not specify their diabetes 
condition as a determinant for changes in smoking behaviour.  
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Whilst self-image was seen as an antecedent to initiate smoking, it was later perceived as a 
reason to quit due to reform of social norms. The importance of appearance was inferred in 
previous research (Regber & Kelly, 2007) but changes in societal views on smoking had not 
been emphasised before. Most participants attempted to stop smoking and their decision to quit 
was due to several factors including health. This was similarly echoed across elderly patients 
with diabetes who quit smoking (Banerjee, 1989). Additional reasons to stop smoking included 
the costly value of cigarettes, which was also mentioned by young patients with T1D and adults 
with T2D (Chau et al., 2015; Regber & Kelly, 2007). This is not a surprise as tobacco control 
measures have increased cigarette prices to reduce smoking rates and the impact of tobacco 
taxation has been successful in reducing smoking prevalence and increasing quitting rates 
(Wilson et al., 2012).  
In previous research, weight and food management were noted as primary reasons to continue 
smoking, particularly among T2D patients who present comorbidity of obesity along with their 
condition (Chau et al., 2015; Iglay et al., 2016). Thus, smoking is considered as a means to 
regulate weight and food intake. However, these concerns have also been expressed by a 
minority of individuals with T1D (Haire-Joshu, Heady, Thomas, Schechtman, & Fisher, 1994; 
Rosenfeld, Wakefield, & Roberts, 1997; Wakefield, Roberts, Rosenfeld, 1998). In contrast to 
previous findings, weight was not a cause for concern within the current study population. It is 
plausible that the discrepancies between the present and earlier findings might reflect on the 
age differences between the participants as T1D adolescents are more likely to report concern 
over shape and weight (Bryden et al. 1999) than that reported by older adults in the present 
study; suggesting that priorities differ between various age groups. 
“Impulses” that drive individuals to continue or quit smoking represents another facet of the 
PRIME model. Addiction and cravings to cigarettes sustained the smoking behaviour of 
patients with T1D. This compulsion was previously narrated by 50% of adult patients with 
diabetes who relapsed due to their cravings (Ardron, MacFarlane, Robinson, Heyningen, & 
Calverley, 1988). The perceived reliability of cigarettes also warranted their continued use and 
this notion was documented in individuals with and without diabetes (Padmawati et al., 2009; 
Uppal et al., 2013). In addition, the physical act of smoking was seen as a notable challenge in 
the quitting process. Altogether, it appears that a combination of internal and external forces 
mediates an individual’s impulses to continue smoking.  
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The habitual act of smoking, peer pressure and lack of will power were commonly experienced 
and perceived as barriers during their quit attempts. These issues were also expressed in 
patients with T2D and the general population (Chau et al., 2015; Uppal et al., 2013). 
Interestingly, none of the participants mentioned their diabetes as a barrier to quitting, which 
is in accord to the perception of individuals with T1D from previous exploratory studies (Haire-
Joshu et al., 1994; Rosenfeld et al., 1997). 
Overall, most smokers with T1D within this sample claimed that they were not motivated give 
up smoking. Although some showed cognitive dissonance towards smoking, their lack of 
“motivation” superseded their need to quit; addressing the fourth aspect of the PRIME 
paradigm. Their desire to quit was not compelling enough to do so, despite their beliefs on the 
lack of health benefits of smoking. Therefore, higher levels within the motivational framework 
will need to be addressed that focus on beliefs and intentions, which would ultimately influence 
their motives and subsequent actions.  
Most participants were in support of being informed on the associative risks of smoking on 
their diabetes, which may in part help re-evaluate their views on smoking. Several believe that 
smoking worsens their diabetes symptoms; whilst a few of the study population believe that 
smoking and diabetes are two separate entities and not interlinked. To date, no studies have 
addressed enhancing education uptake on smoking cessation for patients with diabetes, and 
assessing whether increased knowledge would improve their self-efficacy. Two previous 
studies report the need for tailored educational programmes on smoking cessation for people 
with diabetes and the need to improve care delivery by health professionals (Uppal et al., 2013; 
Rosenfeld et al., 1997).  
Social support was voiced as a probing factor to encourage smoking cessation in people with 
T1D and these views were similarly shared by smokers with T2D whereby family support 
increased their quitting attempts (Chau et al., 2015); suggesting that family or peer 
interventions may elicit higher quitting success. For some, public smoking bans elicited 
positive changes in smoking behaviour in some participants, by reducing their intake of 
cigarettes. These responses were similarly observed in a time trend analysis assessing the effect 
of a smoking ban policy on tobacco consumption and smoking prevalence in Italy (Gualano et 
al., 2014). Although, a Cochrane review of 24 studies illustrated that the evidence on the impact 
of legislative smoking bans is inconsistent, with some studies showing no changes in smoking 
prevalence (Frazer et al., 2016). Discrepancies in smoking outcomes and the effectiveness of 
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smoking bans may be confounded by the implementation of prior tobacco control policies, the 
extent of public support and level of enforcement (Wilson et al., 2012).  
According to PRIME, an individual’s “evaluations” inform their motives and intentions to 
plan a certain course of behaviour (West, 2006). This view represents another component of 
the addiction model. Throughout the literature, it is apparent that people with diabetes are 
aware of the general health risks of smoking. However, their knowledge of the direct link 
between smoking and their diabetes is limited (Padmawati et al., 2009; Rosenfeld et al., 1997; 
Wakefield et al., 1998). Moreover, individuals with T1D do not believe that smoking 
exacerbates their diabetes condition as most report that their diabetes symptoms are controlled.  
The reported poor awareness in the associative link between smoking and diabetes was partly 
attributed to minimal engagement by health care providers. This was also reported elsewhere 
in prior studies, illustrating limited support from clinicians encouraging appropriate behaviour 
changes to quitting smoking (Padmawati et al., 2009; Solberg, Desai, O’Connor, Bishop, & 
Devlin, 2004; Rosenfeld et al., 1997; Wakefield et al., 1998). Involvement of health services 
could improve quitting attempts in people with T1D by enhancing their uptake of smoking 
cessation.   
Most smokers who used NRT claimed that they were ineffective in seizing both the physical 
and mental habitual cravings associated with smoking. The suitability of NRT has been 
questioned in the past, particularly since their use has not been explained to patients seeking to 
quit. This concern was previously raised by individuals with diabetes (Gill, Morgan, & 
MacFarlane, 2005; Rosenfeld et al., 1997) and non-diabetes as well (Uppal et al., 2013). The 
limited education and knowledge on the associative risks of smoking on diabetes have been 
previously mentioned and were partially attributed to minimal health care support (Padmawati 
et al., 2009) and lack of structured educational programmes on smoking cessation (Grant, Haq, 
& Barnes, 2012). Smokers with COPD shared similar views reporting that they were uncertain 
about the relationship between smoking and their condition (van Eerd, Risor, van Rossem, van 
Schayck, & Kotz, 2015). Moreover, smokers with COPD were not informed on the hazards of 
smoking on their respiratory health (van Eerd et al., 2015).  Thus, smoking cessation services 
should provide explicit information about their products to validate the suitability and 
effectiveness of these approaches to individuals with chronic conditions.  
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Study limitations 
This study allowed in-depth exploration into the experiences of smokers with T1D, unravelling 
meanings behind those experiences and yielding richness in data. One limitation of the study 
included phone interviews resulting in loss of nonverbal information, which may affect the 
contextual interpretation of responses. However, to minimise researcher bias and increase 
validity of the current findings, investigator triangulation was accomplished by two authors 
carrying out independent analyses simultaneously. Results were then compared and reviewed 
to develop more broad understanding of the studied phenomenon based on each of the 
investigator’s perspective. Differences in data interpretation were resolved through consensus. 
The different interviewing medium employed may affect the data quality and level of insight 
obtained. However, previous research notes suggest that data quality is not compromised when 
using either telephone, Skype or face-to-face interviewing. Offering choices on preferred 
communication platforms provides benefits to both the researcher and interviewer (Hanna, 
2012; Sturges & Hanrahan, 2004). In the current study, there was no overt difference in the 
depth of insight gained through the different modes of interviewing. Nonetheless, future studies 
should explore the impact of different interviewing platforms on the quality of interview data 
or level of insight sought to determine the most optimal interviewing method in qualitative 
research. Another limitation was that the small sample size of the studied population may not 
be representative of all smokers with T1D. Only one participant was identified as an occasional 
smoker and their smoking and quitting experiences were similar to that of current regular 
smokers; suggesting that factors other than nicotine dependence may have a more profound 
influence on the smoking behaviour of both regular and occasional smokers. Although, this 
notion would need to be verified with a larger cohort of occasional smokers. 
 
Conclusion 
Quitting smoking among people with T1D is a challenging process faced by internal and 
external barriers. Whilst ample services and products for smoking cessation do exist, many 
criticized their usefulness and reported several adverse events. Moreover, limited knowledge 
about the effects of smoking on diabetes and limited support from health care providers appears 
to dissuade them from stopping smoking. Future studies should focus on developing multi-
modal smoking cessation interventions that encompass educational and behavioural support, 
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along with pharmacotherapy to control the psychological and physical addictions associated 
with tobacco consumption.  
 
Relevance to clinical practice 
This study identified knowledge gaps that hinder successful opportunities for patients with T1D 
to quit smoking. These individuals experience various challenges during the quitting process 
in which existing smoking cessation strategies do not support. Increasing the number of quit 
attempts and enhancing the success rate of attempted quitters can be achieved by: 
• Ensuring that physicians and nurses assess the smoking profile of patients by documenting 
smoking status at annual reviews.  
• Providing clear advice to all patients who smoke to stop the habit.  This should be 
personalised and linked to their diabetes. 
• Providing referrals to smoking cessation services and follow ups within 4-weeks’ time 
frame. 
• Improving accessibility to pharmacotherapy and behavioural support for those who do not 
wish to be referred to smoking cessation services by providing information leaflets on 
different products and auditing secondary care patient records for successful quitting 
attempts.  
Future qualitative studies should identify potential barriers and facilitators affecting the 
delivery of smoking cessation support by diabetes clinicians which could inform the 
development of training programmes to enhance staff education on the associative risks of 
smoking and diabetes, as well as providing information on the use of NRT. This could empower 
health care providers to deliver high quality patient care and encourage smoking cessation 
interventions that are appropriate for patients with chronic conditions. 
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Figure 1. Emergent themes and subthemes in accordance to the PRIME theory 
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Opening question Describe your smoking history. When did you first smoke? Why did 
you first start smoking? How much do you smoke? Are there any 
changes in your smoking pattern? If so, what are the reasons? 
Medical history of diabetes How did you feel when you were first diagnosed with diabetes? How 
do you manage it? How does diabetes impact your lifestyle and what 
are the challenges that you face? 
Beliefs about smoking Are you satisfied with your current health? Do you think smoking has 
affected your diabetes in any way? Why do you think you continue 
to smoke? In your opinion, what are the perceived benefits of 
smoking? 
Plans to continue or quit 
smoking 
Have you ever attempted to quit smoking?  
If yes, tell me about your quit attempt. What motivated you to quit? 
How did you distract yourself when you were feeling like having a 
cigarette? What did you find difficult when quitting smoking? 
If no, then what factors prevented you from quitting smoking? 
If you decided to quit smoking, how would you distract yourself if 
you felt like having a cigarette? What factors would influence your 
decision to stop smoking? 
Barriers to quitting Were there times when you wanted to give up quitting smoking? Yes 
= what did you do to carry on quitting? No = how did you stay 
focused to quitting? 
What would be the main reasons for you to continue to smoke or 
relapse? 
Did other people make it difficult for you to quit? Yes = who and 
how? No = explain 
Perception of existing 
smoking cessation policies 
and services 
What services have you explored to quit smoking? 
What methods of quitting have or have not worked for you in the 
past and why? 
Have you ever received advice? 
Closing question Have there been any external factors that have influenced your 
smoking behaviour? Explain.  
 
Table 1. Topic guide for semi-structured interviews 
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Characteristics Frequency  Percentage 
Demographics   
Mean age (S.D.) 33.7 ± 13.3  
Sex 
Male 
Female 
 
8 
4 
 
66.7 
33.3 
Marital status 
Single 
Married/Common-law 
Widowed/Separated/Divorced 
Education level 
Secondary 
Postsecondary/tertiary 
Ethnicity (white) 
 
7 
4 
1 
 
4 
8 
12 
 
58.3 
33.3 
8.3 
 
33.3 
66.7 
100 
Employment status 
Employed 
Unemployed 
 
10 
2 
 
83.3 
16.7 
Diabetes Profile 
Mean age at diagnosis (S.D.) 
Duration of diabetes in years (S.D.) 
Diabetes treatment 
Multiple daily injections 
Twice daily insulin 
Insulin pump 
Smoking Profile 
Smoked 100 cigarettes in lifetime 
Mean number of cigarettes/day (S.D.) 
Time to first cigarette 
Morning 
Afternoon 
Evening 
Other 
Quitting attempts 
 
17.9 ± 15.1 
15.7 ± 10.2 
 
8 
1 
3 
 
 
12 
8.2 ± 5.4 
 
7 
2 
2 
1 
11 
 
 
 
 
66.7 
8.3 
25 
 
 
 
100 
 
 
58.3 
16.7 
16.7 
8.3 
91.7 
 
Table 2. Characteristics of smokers with T1D 
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Plans to alter smoking behaviour  
Subthemes Quote 
 
Independent decision-making 
 
Intended strategies for 
smoking cessation  
Support system 
 
 
Home restrictions 
 
 
Conditional rules 
 
Setting goals 
 
 
“I think, for me, it’s….no-one can help you. It’s like it’s all in your brain 
and mind. It’s all up to you.” (Male P7, age 27) 
 
 
[Asked where they would go for advice for quitting smoking] “My 
doctor, I think.” (Female P1, age 25) 
 
“We’re trying not to smoke at home because I never smoke cigarettes in 
the house.” (Male P8, age 35) 
 
“While I don’t have money, I won’t smoke.” (Male P7, age 27) 
 
“If I manage to smoke one less a day than I did last, that’s a step 
forward.” (Male P11, age 31) 
  
 
Table 3. Key subthemes representing the “plans” component of the PRIME theory. 
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Smoking behaviouR in type 1 diabetes patients 
Subthemes Quote 
Smoking initiation 
Social acceptability  
 
 
Self-image 
 
 
Diabetes diagnosis 
 
Smoking habits 
 
“I was very young and wanted to be like everyone else.” (Female P5, 
age 52)  
 
“Just thought I’m being very grown-up and cool by having cigarette in 
my mouth.” (Male P8, age 35)  
 
“It was after I got diagnosed with diabetes that I started smoking.” 
(Male P3, age 33) 
 
Routine 
 
 
Time limitations 
 
Changes in smoking pattern 
External influences 
 
 
Health awareness 
 
 
 
Adoption of new norms 
 
 
 
 
Experiences of quitting 
smoking 
Reasons to quit smoking 
 
 
Strategies used to quit smoking 
 
 
“I will say when I'm drinking, which is sociable, you know, I do enjoy a 
cigarette.” (Female P5, age 52) 
 
“If I’ve got lots to do and I’m distracted, I’ll only have one break.” 
(Female P13, age 29) 
 
“So I think I did kind of cut down once I started working.” (Male P3, 
age 33) 
 
“I think since then I probably smoke between 10 and 20 cigarettes a day 
until I got diagnosed with diabetes; then I tried to cut down.” (Male P8, 
age 35)  
 
“When the cigarette ban came in, then that was very social to go – to 
leave the bar and stand outside and smoke a cigarette and spend half 
the night outside, actually smoking cigarettes, rather than dancing like 
everyone else was, and I’m thinking, this is so cool. This is the new social 
thing, this smoking outside.” (Male P8, age 35) 
 
 
I did (stop smoking) when I was diagnosed diabetic, so I did for a couple 
of months.” (Female P9, age 48)  
 
“When I have tried to stop smoking I've done it through Stop Smoking 
Service at like Boots Pharmacy and because I'm diabetic I can actually 
get the lozenges and patches and so on free of charge so that obviously 
helps.” (Male P12, age 35)  
 
 
Table 4. Key subthemes representing the “responses” component of the PRIME theory. 
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Urges that Influence smoking behaviour 
Subthemes Quote 
Impulses to continue smoking 
Attitude towards smoking 
cessation 
 
Non-smoker identity 
 
Barriers to quitting  
 
“I don’t have it (quitting) in my mind, so I’m OK with smoking” (Male 
P7, age 27) 
 
“You're on 2 cigarettes a day, you're not really smoking.” (Male P2, age 
50) 
 
Cravings 
 
 
 
 
 
Reliability of cigarettes 
 
 
Addiction to the physical act of 
smoking  
 
 
Associative cues 
 
 
Lack of support 
 
 
 
Secrecy 
 
 
 
Prioritising health conditions 
 
 
 
 
Unfortunate circumstances 
 
“I think it’s just that – it’s the fear of – it’s like your best friend. It’s 
something you’re addicted to, something that makes you feel better, even 
though you know that it only makes you feel better because moments ago 
you were feeling worse, ’cause you had the craving.” (Female P13, age 
29) 
 
“Because it’s very reliable, the cigarette’s always there for you, it’s 
always going to have the same effect.” (Male P11, age 31) 
 
“I don't think smoking an e-cigarette is a good way to try and give up 
smoking cigarettes cause kind of you're still doing the action.” (Male, 
P3, age 33)  
 
“When I went out and I was having a drink, a cigarette was a must.” 
(Male P8, age 35) 
 
“The reason I had a cigarette was because she was smoking, I had a bad 
day, and I just said, Oh, I’ve had a bad day. Can I pinch a cigarette?” 
(Female P13, age 29) 
 
“I think external factors maybe my parents, with them not knowing that 
I smoke, influenced in terms of being able to chain smoke so easily. 
(Female P13, age 29) 
 
“I guess I just I feel like there’s so much kind of going on right now um 
with like my mental health and this that and the other that I’m just kind 
of like do you know what I’ll just cross that bridge when I come to it.” 
(Female P1, age 25) 
 
“I've kind of been in and out of work through lapses of depression, so I 
think that’s been part of it.” (Male P12, age 35) 
 
 
Table 5. Key subthemes representing the “impulses” component of the PRIME theory. 
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Motives to quit smoking 
Subthemes Quote 
 
Lack of motivation to quit 
 
Cognitive dissonance towards 
smoking cessation  
 
“Just lack of commitment and willpower.” (Male P11, age 31) 
 
“Even as a non-diabetic who smokes, you know what the risks are. You 
know, heart disease, lung cancer, nerve damage – just, you know, all of 
the horrible things that come with it, but people still do it anyway.” 
(Female P13, age 29) 
Factors that maintain quitting 
smoking 
Physical distractions 
 
 
Meditation 
 
 
Provision of educational 
support 
 
 
 
 
Peer support 
 
 
 
Public smoking bans 
 
 
 
Healthy lifestyle 
 
 
Breaking the habit 
 
 
 
 
 
“Find something in the house to do, whether it be cook, wash clothes.” 
(Female P5, age 52)  
 
“I just keep telling yourself, just keep calm. Keep calm. The craving’s 
going to go in five minutes and you’ll be fine again.” (Male P8, age 35) 
 
“I think if someone explained to me how diabetes and smoking’s linked 
and how it’s not is it even good for you I know smoking’s not good for 
you anyway but if it was affecting the diabetes then if somebody 
explained how that’s working then yeah I probably would give up 
anyway of my own accord.” (Male P10, age 39) 
 
“A friend of mine, he stopped smoking and stopped drinking alongside 
with me, it was kind of a deal that we went into together.” (Male P11, 
age 31) 
 
“Not being able to smoke inside pubs and venues and so on obviously 
cuts down the amount that you smoke when you go out.” (Male P12, age 
35) 
 
“I got really healthy and fit and kind of realised that I didn't need to 
smoke.” (Male P12, age 35) 
 
“I think that (nicotine patches) definitely helps take the craving away 
and then I think it's the kind of...it's the breaking the habit.” (Male P3, 
age 33) 
 
Table 6. Key subthemes representing the “motives” component of the PRIME theory. 
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BEliefs about smoking and smoking cessation 
Subthemes Quote 
Reasons for smoking 
Emotional support 
 
 
Alone time 
 
 
 
Enjoyment 
 
 
“I still feel like it's kind of a stress relief type thing. It does make me feel 
more relaxed.” (Male P3, age 33) 
 
“Just three or four minutes that no-one can interrupt you with, you go 
round the back of the building, that’s smoker’s corner, don't interrupt 
me.” (Male P11, age 31) 
 
“I think it (smoking) is association with pleasure.” (Female P9, age 48) 
Awareness of health risks in 
T1D smokers 
Lack of knowledge 
 
 
Limited support from health 
care providers  
 
Evaluation of smoking 
cessation interventions 
Negative experiences using 
NRT 
 
 
 
Problems with countering the 
habitual acts of smoking  
 
 
Ineffectiveness of e-cigarettes 
 
 
“Well, because I’m Type 1 diabetic, then I don’t think it (smoking) would 
impact on me.” (Female P13, age 29) 
 
[Asked about whether they were informed if there was a link between 
smoking and diabetes]…. “They said it’s not good.” (Male P10, age 39) 
 
 
 
“I didn't realize was that it (nicotine patch) was releasing nicotine 24 
hours a day. So course you couldn't get to sleep…. So I then tried using 
a lower dose and then taking the patch off before I went to bed or photo 
film but again it was...it kind of irritated my skin.” (Male P2, age 50) 
 
“I tried the inhalers and e-cigarettes, but I didn’t feel like this is actually 
helping me because I still have the habit of I’m doing something.” (Male 
P8, age 35) 
  
“I think the e-cigarette thing is I'm not convinced that they're any 
healthier than normal cigarettes…. I think with e-cigarettes I would end 
up smoking them more probably than I would lighting up a normal 
cigarette just because of the kind of ease and being able to smoke them 
in more places than a normal cigarette.” (Male P12, age 35) 
 
 
Table 7. Key subthemes representing the “evaluations” component of the PRIME theory. 
 
 
 
 
 
 
